An analysis of CJC-1295’s Drug Affinity Complex mechanism, its effect on GHRH receptor persistence, and the resulting modulation of GH pulse amplitude in preclinical and early human research.

A review of CJC-1295’s drug affinity complex technology, covalent albumin-binding mechanism, and current preclinical understanding of GHRH receptor desensitization and somatotroph refractory period dynamics.

← Back to The GH Pulse Compound Overview CJC-1295 is a synthetic peptide analog derived from the first 29 amino acids of endogenous growth hormone-releasing hormone, a hypothalamic signaling molecule that governs pituitary GH secretion. The native sequence, referred to as GHRH(1-29)NH2, retains the full biological activity of the complete 44-residue hormone but degrades rapidly […]